Satellite 1 - Sanofi | State-of-the-art NK cells therapies in hematological malignancies
Presenters: Xavier Poiré, Sébastien Anguille, Evren Alici, Eric Vivier -
Feb 2, 2024
Chairs: Xavier Poiré
- Cell biology of NK cells
Sébastien Anguille, Antwerp University Hospital, Belgium
- NK cell therapies
Evren Alici, Huddinge Karolinska Institutet, Stockholm, Sweden
- Strategies to Enhance NK Cell Therapy Efficacy Clinical aspect of NK cell engagers (NKCE)
Eric Vivier, (Aix-Marseille University / Public Hospital of Marseille (AP-HM), France